Fucoidan at top of ‘blooming’ algae market
Posted Thursday 16 May 2019
According to the report, the global algae products market is expected to reach $3.3 billion by 2022, at a compound annual growth rate of 6.7%. This advancement is largely being driven by an increased interest and use of algae ingredients in nutritional applications.
Marinova’s Chief Scientist, Dr Helen Fitton, explained:
“Consumers are seeking nutritional products containing sustainable and scientifically-backed ingredients – seaweed satisfies both of these demands”.
Fucoidan is recognised as a leading algae ingredient, alongside other well-known derivatives such as Astaxanthin and Omega-3. Its popularity in nutraceutical and cosmetic applications continues to grow year on year.
As the only producer of certified-organic fucoidan with global regulatory acceptance, Marinova continues to set the standard for evidence-based products among fucoidan suppliers. Marinova has a rich pipeline of new research set for 2019 and beyond, with a new gut microbiome clinical study recently commenced and just published cancer research.